Published in Obesity and Diabetes Week, February 16th, 2004
The technology uses a hand-held device that delivers inhaled insulin with the same units as conventionally injected insulin.
A small number of normal humans were involved in the clinical trial. Alveair insulin was administered exactly like the current clinical practice of insulin injection. The only difference is that, in this case, humans in the trial inhaled Alveair insulin without any need to use a needle.
The trial was administered with a single dose, two periods crossover design, with an in-between...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week